What do others say?
“In-House Impact looks set to occupy a truly unique and invaluable space in the industry, geared specifically towards General Counsels and their in-house teams within Life Sciences, furthering Legal’s role as a critical business growth enabler.”
Marcela Kirberger, General Counsel & Secretary, Roche Diagnostics Corporation
“In-House Impact’s mission to define the new standard for in-house lawyers and transform legal technicians into enterprise leaders is absolutely spot on, and a must for any Life Sciences organization.”
Laurie Keating, Executive Vice President & Chief Legal Officer, Alnylam Pharmaceuticals
“This unique platform for in-house teams to discuss the future of their own function within the Life Sciences, sharing concrete examples of how they’re adding even more value to the business, is set to revolutionize how we operate as legal professionals.”
Lisa Matovcik, Assistant General Counsel, GSK
"Most of us have access to a small number of fellow GCs we can reach out to for advice, but very few of us are part of a wider industry-specific community of GCs able to discuss and debate the future of our legal function. This is why I’m excited to be a part of In-House Impact: Life Sciences, to enhance and facilitate those invaluable relationships"
Jonathan Biller, Chief Legal Officer, Agios Pharmaceuticals
"Understanding how we can maximize our impact as legal professionals is a critical part of the role, so I’m excited to take part in In House Impact: Life Sciences and understand the concerns and issues facing my peers, not just as legal professionals, but as leaders within the Life Sciences"
Maria E. Pasquale, Executive Vice President & General Counsel, Incyte
Why should I attend with my team?
“I’m really excited to build out my network and upskill my team in this unique space, with a new community of like-minded, strategic-focused General Counsels and their teams.”
Christine Pellizzari, Chief Legal Officer, General Counsel & Secretary, Insmed
“This event provides a unique opportunity for General Counsels and their teams to rise to the challenge of building a more colleague-centric and driven legal team, moving from risk minimizers to business-critical partners.”
Beth Zelnick-Kaufman, Chief Legal Officer, The Broad Institute of MIT & Harvard
“In-House Impact: Life Sciences offers a unique proposition for us legal professionals, to come together as a community to discuss the future of our profession and how we can best broaden our own expertise as business partners.”
Christine Bellon, Chief Legal Officer, Beam Therapeutics
“This forum provides a unique opportunity for leaders of in-house teams in the Life Sciences… designed to help not just leaders, but whole legal departments in executing on their business objectives.”
Shaun Ryan, Senior Vice President & Deputy General Counsel, Moderna Therapeutics